Citi raises AstraZeneca earnings forecast and maintains 'buy' rating ahead of second-half pipeline catalysts

Citi raises AstraZeneca earnings forecast and maintains 'buy' rating ahead of second-half pipeline catalysts

Original Source

Read the full article at Finance →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.